Jordi Riba
Jordi Riba
Dirección de correo verificada de - Página principal
Citado por
Citado por
Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba, M Valle, G Urbano, M Yritia, A Morte, MJ Barbanoj
Journal of Pharmacology and Experimental Therapeutics 306 (1), 73-83, 2003
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
FL Osório, RF Sanches, LR Macedo, RG Dos Santos, JP Maia-de-Oliveira, ...
Brazilian Journal of Psychiatry 37 (1), 13-20, 2015
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
J Riba, A Rodríguez-Fornells, G Urbano, A Morte, R Antonijoan, ...
Psychopharmacology 154 (1), 85-95, 2001
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study
JC Bouso, D González, S Fondevila, M Cutchet, X Fernández, ...
PLoS One 7 (8), e42421, 2012
Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant
J Riba, S Romero, E Grasa, E Mena, I Carrió, MJ Barbanoj
Psychopharmacology 186 (1), 93-98, 2006
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study
RF Sanches, F de Lima Osório, RG dos Santos, LRH Macedo, ...
Journal of clinical psychopharmacology 36 (1), 77-81, 2016
Assessment of addiction severity among ritual users of ayahuasca
JM Fábregas, D González, S Fondevila, M Cutchet, X Fernández, ...
Drug and alcohol dependence 111 (3), 257-261, 2010
Pattern of use and subjective effects of Salvia divinorum among recreational users
D González, J Riba, JC Bouso, G Gómez-Jarabo, MJ Barbanoj
Drug and alcohol dependence 85 (2), 157-162, 2006
The internationalization of ayahuasca
BC Labate, H Jungaberle
LIT Verlag Münster, 2011
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
F Palhano-Fontes, D Barreto, H Onias, KC Andrade, MM Novaes, ...
Psychological medicine 49 (4), 655-663, 2019
Dopamine agonist increases risk taking but blunts reward-related brain activity
J Riba, UM Krämer, M Heldmann, S Richter, TF Münte
PLoS One 3 (6), e2479, 2008
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the …
RG Dos Santos, FL Osório, JAS Crippa, J Riba, AW Zuardi, JEC Hallak
Therapeutic Advances in Psychopharmacology 6 (3), 193-213, 2016
Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers
J Riba, P Anderer, A Morte, G Urbano, F Jané, B Saletu, MJ Barbanoj
British journal of clinical pharmacology 53 (6), 613-628, 2002
Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution …
J Riba, P Anderer, F Jané, B Saletu, MJ Barbanoj
Neuropsychobiology 50 (1), 89-101, 2004
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans
JC Bouso, F Palhano-Fontes, A Rodríguez-Fornells, S Ribeiro, ...
European Neuropsychopharmacology 25 (4), 483-492, 2015
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
J Soler, M Elices, A Franquesa, S Barker, P Friedlander, A Feilding, ...
Psychopharmacology 233 (5), 823-829, 2016
Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine
RG Dos Santos, M Valle, JC Bouso, JF Nomdedéu, J Rodríguez-Espinosa, ...
Journal of clinical psychopharmacology 31 (6), 717-726, 2011
Ayahuasca: pharmacology, neuroscience and therapeutic potential
E Domínguez-Clavé, J Soler, M Elices, JC Pascual, E Álvarez, ...
Brain research bulletin 126, 89-101, 2016
Noradrenergic stimulation enhances human action monitoring
J Riba, A Rodríguez-Fornells, A Morte, TF Münte, MJ Barbanoj
Journal of Neuroscience 25 (17), 4370-4374, 2005
Psychometric assessment of the hallucinogen rating scale
J Riba, A Rodrıguez-Fornells, RJ Strassman, MJ Barbanoj
Drug and Alcohol Dependence 62 (3), 215-223, 2001
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20